Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-May-23 4:37 PM View:  | 10x Genomics, Inc. (TXG) | 11-May-23 | Option Exercise | 200,000 | $1.16 | $232,000.00 | 7286% 2.75K to 202.75K | |
| 15-May-23 4:37 PM View: | 10x Genomics, Inc. (TXG) | 11-May-23 | Option Sale | 33,000 | $52.82 | $1,743,090.00 | (16%) 202.75K to 169.75K | |
| 17-Jun-22 5:14 PM View: | 10x Genomics, Inc. (TXG) | 15-Jun-22 | Grant | 2,120 | -- | -- | 339% 0.63K to 2.75K | |
| 17-Feb-22 6:00 AM View: | Johnson & Johnson (JNJ) | 15-Feb-22 | Payment of Exercise | 3,366 | $165.89 | $558,386.00 | (7%) 45.3K to 41.93K | |
| 17-Feb-22 6:00 AM View: | Johnson & Johnson (JNJ) | 15-Feb-22 | Option Exercise | 7,740 | -- | -- | 21% 37.56K to 45.3K | |
| 15-Feb-22 8:03 PM View: | Johnson & Johnson (JNJ) | 14-Feb-22 | Payment of Exercise | 2,335 | $168.85 | $394,265.00 | (6%) 39.9K to 37.56K | |
| 15-Feb-22 8:03 PM View: | Johnson & Johnson (JNJ) | 14-Feb-22 | Option Exercise | 7,418 | -- | -- | 23% 32.48K to 39.9K | |
| 15-Jun-21 5:50 PM View: | 10x Genomics, Inc. (TXG) | 11-Jun-21 | Grant | 625 | -- | -- | 100% 0 to 0.63K | |
| 17-Mar-16 7:06 PM View: | Theravance Biopharma, Inc. (TBPH) | 15-Mar-16 | Grant | 90,000 | -- | -- | 45% 198.11K to 288.11K | |
| 23-Feb-16 7:58 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-16 | Payment of Exercise | 19,844 | $15.65 | $310,559.00 | (9%) 217.96K to 198.11K | |
| 24-Nov-15 7:37 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-15 | Payment of Exercise | 934 | $17.17 | $16,036.80 | (< 1%) 218.89K to 217.96K | |
| 24-Aug-15 7:11 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-15 | Payment of Exercise | 934 | $12.98 | $12,123.30 | (< 1%) 219.82K to 218.89K | |
| 04-Jun-15 7:14 PM View: | Theravance Biopharma, Inc. (TBPH) | 02-Jun-15 | Payment of Exercise | 7,360 | $13.83 | $101,789.00 | (3%) 227.18K to 219.82K | |
| 22-May-15 7:13 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-15 | Payment of Exercise | 673 | $14.24 | $9,583.52 | (< 1%) 227.86K to 227.18K | |
| 24-Feb-15 6:55 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-15 | Payment of Exercise | 674 | $19.52 | $13,156.50 | (< 1%) 228.53K to 227.86K | |
| 09-Feb-15 7:46 PM View: | Theravance Biopharma, Inc. (TBPH) | 05-Feb-15 | Grant | 130,000 | -- | -- | 132% 98.53K to 228.53K | |
| 24-Nov-14 7:03 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-14 | Payment of Exercise | 658 | -- | -- | (< 1%) 81.15K to 80.49K | |
| 22-Aug-14 5:02 PM View: | Theravance Inc. (INVA) | 20-Aug-14 | Payment of Exercise | 3,261 | $22.76 | $74,220.40 | (< 1%) 337.3K to 334.04K | 42% |
| 18-Jun-14 7:06 PM View: | Theravance Inc. (INVA) | 16-Jun-14 | Grant | 28,365 | -- | -- | 9% 308.94K to 337.3K | |
| 04-Jun-14 7:49 PM View: | Theravance Inc. (INVA) | 02-Jun-14 | Grant | 71,000 | -- | -- | 30% 237.94K to 308.94K | |
| 12-May-14 7:13 PM View: | Theravance Inc. (INVA) | 09-May-14 | Payment of Exercise | 22,833 | $26.86 | $613,294.00 | (9%) 261.97K to 239.14K | 51% |
| 29-Apr-14 7:01 PM View: | Theravance Inc. (INVA) | 27-Apr-14 | Grant | 37,500 | -- | -- | 17% 224.47K to 261.97K | |
| 12-May-14 7:13 PM View: | Theravance Inc. (INVA) | 13-Mar-14 | Gift | 1,200 | -- | -- | (< 1%) 239.14K to 237.94K | |
| 10-Mar-14 7:06 PM View: | Theravance Inc. (INVA) | 06-Mar-14 | Option Exercise | 42,153 | $14.90 | $627,997.00 | 23% 182.32K to 224.47K | |
| 24-Feb-14 7:11 PM View: | Theravance Inc. (INVA) | 20-Feb-14 | Payment of Exercise | 4,307 | $39.98 | $172,194.00 | (2%) 186.62K to 182.32K | 67% |
| 19-Feb-14 7:13 PM View: | Theravance Inc. (INVA) | 14-Feb-14 | Market Sale (Planned) | 35,000 | $39.36 | $1,377,690.00 | (16%) 221.62K to 186.62K | 66% |
| 22-Nov-13 7:02 PM View: | Theravance Inc. (INVA) | 20-Nov-13 | Payment of Exercise | 4,569 | $36.40 | $166,312.00 | (2%) 226.64K to 222.07K | 64% |
| 14-Feb-14 7:01 PM View: | Theravance Inc. (INVA) | 03-Oct-13 | Gift | 450 | -- | -- | (< 1%) 222.07K to 221.62K | |
| 22-Aug-13 7:02 PM View: | Theravance Inc. (INVA) | 21-Aug-13 | Option Exercise | 18,750 | $16.00 | $300,000.00 | 9% 207.89K to 226.64K | |
| 22-Aug-13 7:02 PM View: | Theravance Inc. (INVA) | 20-Aug-13 | Payment of Exercise | 3,813 | $35.89 | $136,849.00 | (2%) 211.71K to 207.89K | 63% |
| 01-Aug-13 5:33 PM View: | Theravance Inc. (INVA) | 30-Jul-13 | Market Sale (Planned) | 7,000 | $36.51 | $255,570.00 | (3%) 218.71K to 211.71K | 64% |
| 26-Jul-13 7:05 PM View: | Theravance Inc. (INVA) | 24-Jul-13 | Grant | 5,000 | -- | -- | 2% 213.71K to 218.71K | |
| 31-May-13 7:03 PM View: | Theravance Inc. (INVA) | 29-May-13 | Option Exercise | 11,021 | $8.54 | $94,159.40 | 5% 202.68K to 213.71K | |
| 22-May-13 6:55 PM View: | Theravance Inc. (INVA) | 20-May-13 | Payment of Exercise | 3,292 | $37.01 | $121,837.00 | (2%) 205.98K to 202.68K | 64% |
| 02-May-13 7:06 PM View: | Theravance Inc. (INVA) | 30-Apr-13 | Market Sale (Planned) | 7,000 | $33.74 | $236,164.00 | (3%) 212.98K to 205.98K | 61% |
| 22-Feb-13 7:03 PM View: | Theravance Inc. (INVA) | 20-Feb-13 | Payment of Exercise | 5,002 | $22.10 | $110,544.00 | (2%) 224.98K to 219.98K | 40% |
| 22-Feb-13 7:03 PM View: | Theravance Inc. (INVA) | 20-Feb-13 | Market Sale (Planned) | 7,000 | $22.14 | $154,980.00 | (3%) 219.98K to 212.98K | 40% |
| 11-Feb-13 8:29 PM View: | Theravance Inc. (INVA) | 07-Feb-13 | Grant | 5,000 | -- | -- | 2% 219.98K to 224.98K | |
| 14-Jan-13 7:04 PM View: | Theravance Inc. (INVA) | 11-Jan-13 | Option Exercise | 14,510 | $3.10 | $44,981.00 | 7% 205.93K to 220.44K | |
| 14-Jan-13 7:04 PM View: | Theravance Inc. (INVA) | 31-Dec-12 | Gift | 460 | -- | -- | (< 1%) 220.44K to 219.98K | |
| 20-Nov-12 7:05 PM View: | Theravance Inc. (INVA) | 20-Nov-12 | Payment of Exercise | 4,874 | $21.08 | $102,744.00 | (2%) 210.8K to 205.93K | 37% |
| 16-Nov-12 7:01 PM View: | Theravance Inc. (INVA) | 14-Nov-12 | Option Exercise | 5,161 | $3.10 | $15,999.10 | 3% 205.64K to 210.8K | |
| 06-Nov-12 7:01 PM View: | Theravance Inc. (INVA) | 02-Nov-12 | Market Sale (Planned) | 7,000 | $21.45 | $150,162.00 | (3%) 212.64K to 205.64K | 38% |
| 17-Oct-12 7:06 PM View: | Theravance Inc. (INVA) | 15-Oct-12 | Grant | 5,000 | -- | -- | 2% 207.64K to 212.64K | |
| 22-Aug-12 7:03 PM View: | Theravance Inc. (INVA) | 20-Aug-12 | Payment of Exercise | 4,644 | $27.01 | $125,434.00 | (2%) 212.28K to 207.64K | 51% |
| 15-Aug-12 7:05 PM View: | Theravance Inc. (INVA) | 13-Aug-12 | Market Sale (Planned) | 25,000 | $25.74 | $643,461.00 | (11%) 237.28K to 212.28K | 49% |
| 22-May-12 7:21 PM View: | Theravance Inc. (INVA) | 20-May-12 | Payment of Exercise | 3,832 | $20.33 | $77,904.60 | (2%) 241.12K to 237.28K | 35% |
| 22-Feb-12 7:03 PM View: | Theravance Inc. (INVA) | 20-Feb-12 | Payment of Exercise | 9,747 | $18.54 | $180,709.00 | (4%) 250.86K to 241.12K | 28% |
| 17-Feb-12 7:03 PM View: | Theravance Inc. (INVA) | 15-Feb-12 | Grant | 5,000 | -- | -- | 2% 245.86K to 250.86K | |
| 22-Nov-11 7:05 PM View: | Theravance Inc. (INVA) | 20-Nov-11 | Payment of Exercise | 2,250 | $22.34 | $50,265.00 | (< 1%) 248.11K to 245.86K | 40% |